Locoregional recurrence negatively impacts both long‐term survival and quality of life for
several malignancies. For appropriate‐risk patients with an isolated, resectable, local …

While many cancer survivors diagnosed with early-stage disease will outlive their cancer,
they may continue to experience long-term and/or latent side effects due to cancer treatment …

The number of deaths from colorectal cancer in Japan continues to increase. Colorectal
cancer deaths exceeded 50,000 in 2016. In the 2019 edition, revision of all aspects of …

Japanese mortality due to colorectal cancer is on the rise, surpassing 49,000 in 2015. Many
new treatment methods have been developed during recent decades. The Japanese …

Background GRECCAR 2 was the first multicentre, randomised trial to compare local
excision with total mesorectal excision in downstaged low rectal cancer. Encouraging …

Colorectal cancer is a major cause of death in Japan, where it accounts for the largest
number of deaths from malignant neoplasms among women and the third largest number …

Background Organ preservation is a concept proposed for patients with rectal cancer after a
good clinical response to neoadjuvant chemotherapy, to potentially avoid morbidity and side …

Background The TME trial investigated the value of preoperative short-term radiotherapy in
combination with total mesorectal excision (TME). Long-term results are reported after a …

Background Magnetic resonance imaging (MRI) is increasingly being used for rectal cancer
staging. The purpose of this study was to determine the accuracy of phased array MRI for T …

Colorectal cancer is a major cause of death in Japan, where it accounts for the largest
number of deaths from malignant neoplasms in women and the third largest number in men …